(Q43195244)
Statements
1 reference
Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline (English)
1 reference
M Lafeber
1 reference
A M E Stades
1 reference
G D Valk
1 reference
M J Cramer
1 reference
F Teding van Berkhout
1 reference
P M J Zelissen
1 reference
13 January 2010
1 reference
1 reference
162
1 reference
4
1 reference
667-675
1 reference
Identifiers
1 reference
1 reference